The introduction of the three-dimensional (3D) ultrasound made feasible the quantitative and qualitative evaluation of the placenta's characteristics like the volume, the surface rendered imaging, the vascularization and the blood flow. These novel techniques may assist the early detection of pregnancies at high risk for fetal growth restriction (FGR), pre-eclampsia (PET) and pregnancy-induced hypertension (PIH) and help clinicians to detect pregnancies at risk earlier and to assess new therapeutic strategies in order to prevent adverse pregnancy outcomes. However, in this new technique there are still limitations regarding the assessment of the placenta employing 3D ultrasound in everyday clinical practice. In the following article, we perform a review of the literature regarding the importance of 3D evaluation of the placenta in pregnancy.
INTRODUCTION
Pregnancy associated problems like intrauterine growth retardation (IUGR) or pre-eclampsia (PET) are mainly caused by a disturbed placental function. Current models suggest that these problems are related to an impaired invasion of fetal trophoblastic cells in the maternal decidua, which will leads to an impeded transformation of the spiral arteries into vessels of low resistance. 1 This causes reduced blood flow and accordingly leads to hypoxic damage of the endothelial vessels, initiating a range of disorders including placental infraction, increased maternal blood pressure (pregnancy-induced hypertension, PIH) and fetal growth restriction (FGR) among others. Conventional two-dimensional (2D) ultrasound has been widely used for the evaluation of the placenta during pregnancy. This 2D evaluation includes the assessment of the morphology and anatomy of the placenta, identification of its location and evaluation of other placental issues, such as quality of implantation, structural or functional anomalies, placental size and more recently study of color/power and pulsed Doppler characteristics of the placenta. 2, 3 The earlier in pregnancy we identify a risk factor for obstetric complications, the higher the chance that we may find a treatment. Identifying risk factors for PET and IUGR in the first trimester of pregnancy has been a great challenge in obstetrics the last decade. New evidence show that threedimensional (3D) evaluation of the placenta may be a possible method to detect impaired trophoblastic invasion in the first trimester might be. 3D ultrasound has the potential to provide improved visualization of the fetal anatomic morphology compared to the conventional 2D imaging. 3D ultrasound and power Doppler offer a more objective and more detailed method of evaluating placental volume and its vascular network. In 1984, the first placental volumes acquired via sonography were conducted by Brinkley et al. 4 Since, then the progress of technology and the development of 3D sonography (3DUS) imaging assisted by computer technology, has made possible the measurement and calculation of fetal and placental volumes accurately and quickly. This method has been standardized and implemented in everyday practice. What is more 3D power Doppler offers more information on the placental anatomy and function. The Doppler parameters derived from 3D interrogation of the placenta include the vascularization index (VI), the flow index (FI) and the vascularization flow index (VFI).
Aim of this paper is to review all available studies regarding 3D ultrasonographic assessment of the placental morphology, placental volume measurement, and placental vascularization and blood flow.
Evaluation of Placental Abnormality Using 3D Ultrasound
In most cases an exact diagnosis of placental abnormalities can be made using only the 2D ultrasound. However, using the 3D ultrasound, more detailed information on placental abnormalities can be obtained, especially visualization of the continuity and curvature. There have been two reports on placental diagnosis of placental abnormalities using 3D surface rendered imaging. Hata et al in 2004 5 investigated six cases with placental abnormalities and found that visualization of the continuity and curvature of structures was more easily accomplished with the 3D sonography than the 2D. In addition, Abramowicz et al suggested that 3D
surface rendered images provide an entirely new visual experience not only for the examiner, but also for patients and their families, owing to the near-photographic depiction of the placental abnormality in utero.
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Volume Measurement Using 3D Ultrasound
Volume measurements using 3D ultrasound methods are much more accurate than the methods using the 2D ultrasound for regular and irregular shaped objects. Riccabona et al observed that 3D measurement error was only 6.4 ± 4.4% whereas 2D error reached 12.6 ± 8.7% when compared the accuracy of ultrasound for volume measurement. 7 There are three techniques for the placental volume assessment; that is (a) the multiplanar method, (b) the VOCAL (virtual organ computer-aided analysis) method and (c) the XI VOCAL (extended imaging VOCAL) method. Nowac et al in 2007 in a prospective cross sectional study involving 37 pregnant women, evaluated placental volumes in early pregnancy using both multiplanar and VOCAL methods and comparing the results. 8 This study
showed strong correlation between placental volume measured by the VOCAL and the multiplanar methods which are considered to be concordant. Another study by Cheong et al in 2010 showed that XI VOCAL method to be inferior to VOCAL in terms of reliability and validity. 9 The better results of the VOCAL mode can be explained by its ability to allow finer contouring of the object of interest and easier subsequent modification of the contour. In contrast the current XI VOCALmode applies a fixed slice interval and does not take into account the highly variable contour of an irregular subject. There are several studies regarding the volume of the placenta and the prediction of the birth weight percentile. Plasencia et al in a prospective study involving 3,104 singleton pregnancies suggested that combined measurement of placental volume and serum pregnancy associated plasma protein A (PAPP-A) can improve the prediction of small (SGA) or large for gestational age (LGA) fetuses, compared to the prediction provided by maternal characteristics alone. 10 They found that an algorithm combining maternal characteristics with either placental volume or maternal serum PAPP-A can potentially identify about 30% of pregnancies with SGA or LGA, with a false positive rate (FPR) of 10%. 10 However, there was no significant improvement in the performance of screening for SGA or LGA neonates by the addition of placental volume in the combination of maternal factors and serum PAPP-A. There are also two previous studies which have studied the prediction of SGA from first trimester measurements of placental volume. 11, 12 Hafner et al examined 2,489 singleton pregnancies at 11 to 13 +6 weeks of their pregnancy and reported that the detection rate of SGA by measurement of placental volume alone was 27%, with a FPR of 10%. 11 Similarly, Law et al studied 601
pregnancies and reported that the measurement of placental volume at 11 to 13 +6 weeks identified 23% of SGA neonates, with a FPR of 10% and the prediction rate was not improved by the measurement of uterine artery Dopplers or fetal crown rump length (CRL). 13 There are plenty of studies regarding the prediction of adverse pregnancy outcomes including PET and pregnancyinduced hypertension, using placental volume measurement in the first trimester of pregnancy, but their results do not appear to agree on the prognostic value of placental volume measurement. Metzenbauer et al in a study involving 2,863 singleton pregnancies suggested that the median placental quotient (quotient from placental volume and CRL) in the chromosomally abnormal fetuses group, was significantly lower than that in the normal fetuses and they concluded that the assessment of placental volume may prove to be useful in first trimester risk assessment for chromosomal anomalies. 14 Obido et al suggested that the value of placental volume measurement and the interpretation of the results from the measurements depend on the pregnancy complication being studied. 18 In particular they found placental volumes to be lower in the pregnancies with PIH and SGA compared with the placentas of pregnancies with PET. This is consistent with studies that have demonstrated different morphologic characteristics of the placenta in pregnancies with growth restriction compared with PE. 18 However as a screening tool, placental volume was associated with poor predictive efficiency even for SGA and PIH in that study. On the other hand, Haffner et al stated that placental quotient (PQ) is insufficient for the screening of SGA, PET and PIH in low-risk populations. 11 They also reported that the placentas of women with pathologic uterine perfusion in the second trimester of pregnancy are already remarkably small at the end of first trimester. 20 Several studies about the reproducibility of the placentas' volume measurement are available. [19] [20] [21] [22] [23] [24] [25] Bujold et al in 2009 concluded that evaluation of placental volume between 11 and 14 weeks of pregnancy is a feasible and reliable method. 22 In an other study by Huster et al in 2010, it was confirmed that the 3D measurements of the placental volumes are highly reproducible with the intraobserver and the interobserver correlations greater than 0.75, which is considered to be a good agreement. 23 Deurloo et al in 2006 in his study about reproducibility of 3D sonographic measurements of placental volume concluded that this method is highly reproducible both by the same and by Several studies have been conducted to determine the reference values and the ranges of the VI, FI and VFI during pregnancy. Paula et al in a prospective study of 295 singleton, low-risk women found that the placental vascular indicesestimated by 3D power Doppler ultrasonography presented constant distribution throughout gestation, despite the significant increase of the placental volume. 31 This finding suggests that placental vascularization may increase proportionally to the organ volume, contributing to maintaining the placental vascular indices constant throughout gestation. Similar findings were observed by Guiot et al. 27 The results of these studies are considerably different when compared to other studies reported in the literature. Yu et al in 2003 in a study involving 100 normal placentas found that both VI and VFI increased throughout pregnancy. 32 In a later study by Merce et al it was demonstrated that 3D indices correlated significantly with gestational age, although each of them exhibited different behavior. 33 Whereas FI increased in a linear and progressive manner along gestation, the VI increased up to 30 weeks maintaining a plateau up to the 37th week and decreasing after that week of pregnancy. The VFI reflected the behavior of both indices. One possible explanation for these differences in the previous studies is the different sampling method of volume acquisition in the placenta. For example, Yu et al did not describe the volume applied and the place selected to obtain a representative sample of placental vascularization, while Merce et al used the previous reported method of sonobiopsy. Another explanation is the different machines and the machine setting used. There are investigations which provide evidence that machines settings affect VI, FI and VFI calculations. 34 It has been also demonstrated that the position of the placenta attachment in the uterine cavity may affect the measurements. 35 Some authors have stressed that only anterior placentas should be included in their studies to avoid the risk of Doppler signal attenuation. 30 Jones et al suggested that when undertaking 3D ultrasound and power Doppler angiography (3D-PDA) several technical aspects must be considered and she documented that depth depended attenuation of the signal needs to be accounted for in any in vivo work where the probe is not in direct contact with the tissue of interest.
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Vascularization Indices and Adverse Pregnancy Outcome Prediction
Several articles have studied the importance of first trimester placental vascularization indices for the prediction of adverse pregnancy outcomes (Table 1) . Odeh et al 37 in a study with 308 pregnant women during 11 to 13 +6 weeks of gestation suggested that VI may be of some potential in detection of PIH. Obido et al 18 found that the mean vascular indices of first trimester placentas were lower in pregnancies that subsequently developed PET compared to pregnancies who did not develop PET. In addition those pregnancies with both PET and SGA had a significantly lower FI compared tothe control group of unaffected pregnancies. The prediction models for PET using these indices were however, associated with only modest discriminatory ability. These findings were not as significant as previous studies, which had suggested better prediction of PET and SGA using placental volumes and vascularization indices. Rizzo et al 38 in a study with 84 singleton pregnancies which had low PAPP-A levels during the first trimester of pregnancy found that among pregnancies with low serum PAPP-A levels, significant decrease in the 3D power Doppler vascularization indices at 11 to 13 +6 weeks was shown in those pregnancies who had low PAPP-A but also developed IUGR fetuses. A second finding of this study was the significant association between the degree of reduction in the 3D placental Doppler indices and the severity of the growth defects at birth. In another study Bozkurt et al 39 reported that VI values in the placenta at 11 to 14 weeks of gestation show a positive linear correlation with the newborn weight. Several studies have demonstrated the reproducibility of 3DPD ultrasound placental index measurements. Several authors obtained good intra-and interobserver reproducibility employing 3DPD parameters in the placenta. 22, 30, 36 When the visualization of the entire placental tree is not feasible a valid alternative could be placental vascular indices from PVS which show a good correlation with those of the entire placenta.
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CONCLUSION
It is well-established that PET and IUGR is caused by abnormal trophoblastic invasion and pathologic formation of the spiral arteries leading to increased placental resistance and decreased blood flow to the intervillous space. This abnormality in placentation can indirectly be measured and assessed via 2D ultrasound and more specifically through uterine artery Doppler. 44 However, studies show that conventional 2D ultrasound cannot provide the same information as 3D assessment of the placenta. Indeed 3D ultrasonography offers a more direct evaluation of blood flow to the placenta, and it has been shown by many studies that it may lead to earlier recognition of placentas at risk for adverse pregnancy outcomes, such as PET and IUGR or even chromosomal abnormalities. 43 We are now able using this new technique to evaluate more precisely the surface of the placenta, its volume and the placental vascular tree. However, lack of standardization of a universal method that would assess placenta with 3D ultrasound, has delayed the gathering of sufficient data that would allow this method to be applied as a screening tool in everyday clinical practice. Further work is required to establish the effect of other confounding parameters before valid conclusions may be made and a better understanding of 3D power Doppler ultrasound imaging achieved. 38 More studies with standardized machine settings are needed in current practice, in order to draw safe conclusions on the usefulness of 3D assessment of the placenta.
